|
시장보고서
상품코드
1983187
생리활성 펩티드 시장 : 원료별, 치료 영역별, 유통 채널별, 지역별Bioactive Peptide Market, By Source, By Therapeutic Area, By Distribution Channel, By Geography |
||||||
생리활성 펩티드 시장은 2026년에 70억 8,960만 달러로 추계되고 있으며, 2033년까지 133억 2,800만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 9.4%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 70억 8,960만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년의 예측 기간 CAGR : | 9.40% | 2033년 시장 규모 예측 : | 133억 2,800만 달러 |
생리활성 펩티드는 일반적으로 모단백질의 구조 속에 묻혀 있는 생물학적 분자 그룹으로, 단백질이 절단된 후 활성화되는 생물학적 분자 그룹입니다. 또한 또 다른 그룹의 펩티드는 많은 미생물에 의해 활발하게 생성되어 존재합니다. 많은 생리활성 펩티드 그룹이 화학적 또는 재조합 기술을 통해 시장에 출시되고 있습니다. 생리활성 펩티드는 단백질 및 기타 중요한 영양소를 첨가하여 식품에 영양가를 부여하는 성분입니다. 생리활성 펩티드는 심혈관 질환, 당뇨병, 암, 감염성 질환 등 만성질환의 예방 및 관리 등 건강상 이점으로 인해 인기를 끌고 있습니다. 따라서 생리활성 펩티드는 과민성 대장증후군과 같은 기능성 장애의 치료제로 사용되고 있으며, 이는 시장 성장을 촉진할 것으로 예측됩니다.
시장 역학
주요 시장 기업이 폐부종 및 류마티스 관절염 치료를 위한 연구개발에 박차를 가하면서 예측 기간 중 세계 생리활성 펩티드 시장의 성장을 촉진할 것으로 예측됩니다. 예를 들어 2022년 5월 30일 생명공학 기업 APEPTICO Forschung und Entwicklung GmbH는 폐부종 치료제 후보물질인 솔나타이드(Solnatide, 합성 펩티드의 건조 분말 흡입제 및 흡입용 에어로졸 제제)의 3차원 구조와 작용기전이 APEPTICO가 주도하는 국제 과학자 네트워크에 의해 밝혀졌다고 발표했습니다.
또한 2021년 6월, 임상 단계의 생명공학 기업 오리엔 테라퓨틱스(Orin Therapeutics)는 2020년 임상 1a상을 성공적으로 완료한 데 이어, 2021년 6월 DMARDs(질병조절 항류마티스제제)로 치료 중인 류마티스 관절염 환자들을 대상으로 한 무작위배정, 이중맹검, 대조약 대조, 반복투여 비교시험인 임상 1b상 시험의 류마티스 관절염 환자 모집을 시작했습니다.
이 보고서의 주요 특징
- 세계의 생리활성 펩티드 시장을 상세하게 분석하고, 2021년을 기준 연도로 하여 예측 기간(2022-2030년) 시장 규모와 CAGR을 조사하여 전해드립니다.
- 또한 각 부문의 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요 인사이트을 제공합니다.
- 세계 생리활성 펩티드 시장의 주요 기업 개요을 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 매개 변수를 기반으로 정리하여 수록했습니다.
- 이 보고서의 인사이트을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업데이트, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- "세계 생리활성 펩티드 시장" 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 생리활성 펩티드 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 생리활성 펩티드 시장 : 원료별(2026-2033년)
제5장 세계의 생리활성 펩티드 시장 : 치료 영역별(2026-2033년)
제6장 세계의 생리활성 펩티드 시장 : 유통 채널별(2026-2033년)
제7장 세계의 생리활성 펩티드 시장 : 지역별(2026-2033년)
제8장 경쟁 구도
제9장 섹션
KSA 26.04.20Bioactive Peptide Market is estimated to be valued at USD 7,089.6 Mn in 2026 and is expected to reach USD 13,328.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 7,089.6 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.40% | 2033 Value Projection: | USD 13,328.0 Mn |
Bioactive peptides are a group of biological molecules that are normally buried in the structure of parent proteins and become active after the cleavage of the proteins. Another group of peptides is actively produced and found in many microorganisms. Many groups of bioactive peptides have been marketed chemically or recombinantly. The bioactive peptides are ingredients that provide nutritive value to the food by adding protein and other important nutrients. Bioactive peptides are gaining popularity, owing to health benefits such as prevention and control of chronic disease conditions like cardiovascular disease, diabetes, cancer, and infectious diseases. Therefore, bioactive peptides are used as treatment therapy for most of the functional disorders such as irritable bowel disease, which is expected to drive the market growth.
Market Dynamics
Increasing research and development by key market players for the treatment of pulmonary edema and rheumatoid arthritis is expected to drive growth of the global bioactive peptide market over the forecast period. For instance, on May 30, 2022, APEPTICO Forschung und Entwicklung GmbH, a biotechnology company, announced that the 3-D structure and the mechanism of action of Solnatide,( a dry powder inhalation and an inhaled aerosol formulation of a synthetic peptide) a possible treatment for pulmonary oedema, had been disclosed by an international network of scientists led by APEPTICO.
Similarly, in June 2021, Oryn Therapeutics, a clinical stage biotechnology company, had opened recruitment for rheumatoid arthritis patients for a Phase 1b clinical trial, which was a Randomized, Double-blind, Vehicle Controlled, and Repeat Dose Comparative Study in RA (rheumatoid arthritis) Patients Managed with DMARDs (Disease-modifying antirheumatic drugs), whereas the Phase 1a clinical trial study had been successfully completed in 2020.
Key features of the study
- This report provides in-depth analysis of the global bioactive peptide market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2022 - 2030, considering 2021 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
- It profiles key players in the global bioactive peptide market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include, Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., Valio Oy, GenScript, HELIX BIOMEDIX, Oryn Therapeutics, Selecta Biosciences, NIBEC, vivitide, PEPTIDE INSTITUTE, INC, BCN Peptides, Setlance srl., APEPTICO Forschung und Entwicklung GmbH, and BIONANOPLUS
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global bioactive peptide market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global bioactive peptide market
Market Segmentation
- By Source
- Plant
- Milk
- Egg
- Meat
- Fish
- Others (Bacterial Antimicrobial Peptides, Venom Peptidomics)
- By Therapeutic Area
- Antihypertensive
- Antioxidant
- Immunostimulatory
- Antimicrobial
- Diabetes
- Others (Gastrointestinal System, Cardiovascular System)
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others (Drug Store, Mail-Order Pharmacy)
- By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
- Key Players
- Archer Daniels Midland Company
- Seagarden AS
- Phermpep Co. Ltd.
- Arlak Biotech Pvt. Ltd.
- Naturade
- Royal DSM
- MYOS RENS Technology Inc.
- Natural Factors Inc.
- Valio Oy, GenScript
- HELIX BIOMEDIX
- Oryn Therapeutics
- Selecta Biosciences
- NIBEC
- Vivitide
- PEPTIDE INSTITUTE, INC
- BCN Peptides
- Setlance srl.
- APEPTICO Forschung und Entwicklung GmbH
- BIONANOPLUS
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Source
- Market Snapshot, By Therapeutic Area
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Development
- Regulatory Scenario
- Reimbursement Scenario
- Pest Analysis
- Market Potential in Lower economies
4. Global Bioactive Peptide Market, By Source, 2026 - 2033, (US$ Million)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Plant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Milk
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Egg
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Meat
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Fish
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Others (Bacterial Antimicrobial Peptides and Venom Peptidomics)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
5. Global Bioactive Peptide Market, By Therapeutic Area, 2026 - 2033, (US$ Million)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026- 2033
- Segment Trends
- Antihypertensive
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Antioxidant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Immunostimulatory
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Antimicrobial
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Diabetes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Others (Gastrointestinal System and Cardiovascular System)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
6. Global Bioactive Peptide Market, By Distribution Channel, 2026 - 2033, (US$ Million)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Others (Drug Store and Mail-Order Pharmacy)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
7. Global Bioactive Peptide Market, By Region, 2026 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (US$ Million)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Heat Map Analysis
- Company Profile
- Archer Daniels Midland Company
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Seagarden AS
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Phermpep Co. Ltd.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Arlak Biotech Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Naturade
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Royal DSM
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- MYOS RENS Technology Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Natural Factors Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Valio Oy
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- GenScript
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- HELIX BIOMEDIX
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Oryn Therapeutics
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Selecta Biosciences
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- NIBEC
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- vivitide
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- PEPTIDE INSTITUTE, INC
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- BCN Peptides
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Setlance srl.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- APEPTICO Forschung und Entwicklung GmbH
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- BIONANOPLUS
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Analyst Views
9. Section
- References
- Research Methodology
- About Us
